KINIKSA PHARMACEUTICALS, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.78 USD | +0.03% |
|
+1.53% | +13.34% |
| May. 14 | Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM | |
| Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Bio Therapeutic Drugs | +0.56% | +1.53% | +13.34% | +46.61% | +28.34% | 1.4B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KNSA Stock
- Charts Kiniksa Pharmaceuticals, Ltd.
- Comparison Chart
